Profiel
Loretta M. Itri is Chief Medical Officer van Immunomedics, Inc. In het verleden bekleedde zij de functie van Chief Medical Officer bij Genta, Inc., Senior Vice President-Medical & Regulatory Affairs bij Robert Wood Johnson Pharmaceutical Research Institute, Chief Medical Officer & Senior VP-Clinical Affairs bij Ortho Biotech Products LP, Senior Director-Clinical Investigations bij Hoffmann-La Roche, Inc., EVP-Global Health Science & Regulatory Affairs bij The Medicines Co. en Member-Scientific Counselor bij National Cancer Institute. Dr. Itri promoveerde aan het New York Medical College en behaalde een bachelordiploma aan de Long Island University.
Eerdere bekende functies van Loretta Itri
| Bedrijven | Functie | Einde |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2024 |
| THE MEDICINES COMPANY | Algemeen Adviseur | 01-05-2019 |
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 |
| PHARMACYCLICS, INC. | Directeur/Bestuurslid | 09-08-2006 |
Ortho Biotech Products LP
Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Provides innovative products and services to help enhance patients health | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 |
Opleiding van Loretta Itri
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
Ortho Biotech, Inc. | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Long Island University
Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Ortho Biotech Products LP
Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Provides innovative products and services to help enhance patients health | Health Technology |
New York Medical College
New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Pharmaceutical Research Institute
Robert Wood Johnson Pharmaceutical Research Institute BiotechnologyHealth Technology Engages in pharmaceutical research and development | Health Technology |
Aadi Bioscience, Inc.
Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
















